ES2176792T3 - Tabletas que contienen una resina de intercambio ionico. - Google Patents

Tabletas que contienen una resina de intercambio ionico.

Info

Publication number
ES2176792T3
ES2176792T3 ES97944125T ES97944125T ES2176792T3 ES 2176792 T3 ES2176792 T3 ES 2176792T3 ES 97944125 T ES97944125 T ES 97944125T ES 97944125 T ES97944125 T ES 97944125T ES 2176792 T3 ES2176792 T3 ES 2176792T3
Authority
ES
Spain
Prior art keywords
tablets
coated
exchange resin
ion exchange
tablets containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97944125T
Other languages
English (en)
Inventor
Takeshi Goto
Tatsuya Meno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2176792T3 publication Critical patent/ES2176792T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Abstract

SE DESCRIBEN COMPRIMIDOS HIPOCOLESTEROLEMIANTES RECUBIERTOS O NO RECUBIERTOS PARA LA ADMINISTRACION ORAL, QUE INCLUYEN UNA RESINA DE INTERCAMBIO ANIONICO DE FORMULA (I), EN LA CUAL X REPRESENTA UN CONTRAION FISIOLOGICAMENTE ACEPTABLE; Y P REPRESENTA UN GRADO MEDIO DE POLIMERIZACION, Y ES MAYOR QUE 10.000, DIOXIDO DE SILICIO Y CELULOSA CRISTALINA, PERO QUE NO CONTIENEN AGUA. LOS COMPRIMIDOS NO RECUBIERTOS SE RECUBREN PREFERIBLEMENTE CON SUSTANCIAS CELULOSICAS. LOS COMPRIMIDOS SON FACILES DE TOMAR, PUESTO QUE NO SON AMARGOS. LA DOSIS DE LOS COMPRIMIDOS PUEDE DISMINUIRSE, PUESTO QUE LOS COMPRIMIDOS PUEDEN CONTENER UNA GRAN CANTIDAD DE PRINCIPIO ACTIVO. LA MEZCLA QUE INCLUYE LOS COMPONENTES CONSTITUYENTES PUEDE FORMARSE DIRECTAMENTE EN COMPRIMIDOS EN AUSENCIA DE AGUA.
ES97944125T 1996-10-15 1997-10-15 Tabletas que contienen una resina de intercambio ionico. Expired - Lifetime ES2176792T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29332896A JP4010585B2 (ja) 1996-10-15 1996-10-15 陰イオン交換樹脂を含有する錠剤

Publications (1)

Publication Number Publication Date
ES2176792T3 true ES2176792T3 (es) 2002-12-01

Family

ID=17793408

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97944125T Expired - Lifetime ES2176792T3 (es) 1996-10-15 1997-10-15 Tabletas que contienen una resina de intercambio ionico.

Country Status (16)

Country Link
US (1) US6197290B1 (es)
EP (1) EP0873129B1 (es)
JP (1) JP4010585B2 (es)
KR (1) KR19990072020A (es)
CN (1) CN1111413C (es)
AT (1) ATE216248T1 (es)
CA (1) CA2240402A1 (es)
DE (1) DE69712033T2 (es)
DK (1) DK0873129T3 (es)
ES (1) ES2176792T3 (es)
ID (1) ID21038A (es)
PT (1) PT873129E (es)
RU (1) RU2180219C2 (es)
TW (1) TW528605B (es)
UA (1) UA51686C2 (es)
WO (1) WO1998016237A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69912389T2 (de) * 1998-08-05 2004-07-22 Hisamitsu Pharmaceutical Co., Inc., Tosu Verfahren zur herstellung von kationischem polymer
US6413394B1 (en) * 1999-07-08 2002-07-02 Thomas Y. Shen Disposable plate electrode with biological active film
ES2350307T3 (es) 2000-09-06 2011-01-20 Mitsubishi Tanabe Pharma Corporation Preparaciones granulares para administración oral.
EP1348442A4 (en) * 2000-11-28 2005-02-02 Mitsubishi Pharma Corp ANTI-OBESITY AGENTS AND DIET FOOD
CN1953756A (zh) 2004-03-26 2007-04-25 三菱制药株式会社 胰岛素抗性改善剂
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
ES2398477T3 (es) 2006-06-16 2013-03-19 Mitsubishi Tanabe Pharma Corporation Agente para la prevención y/o el tratamiento de glomerulopatía
US20090252794A1 (en) * 2006-08-09 2009-10-08 Tetsuya Suzuki Tablet
RU2668499C2 (ru) * 2015-03-12 2018-10-01 Закрытое Акционерное Общество "Фармфирма "Сотекс" Фармацевтическая композиция в форме таблеток, покрытых кишечнорастворимой оболочкой, и способ ее получения
CN107233933A (zh) * 2017-05-09 2017-10-10 安徽皖东化工有限公司 一种水体净化用苯乙烯阴离子交换树脂的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI67483C (fi) * 1977-02-17 1985-04-10 Merck & Co Inc Foerfarande foer framstaellning av ett icke adhesivt friflytande farmakologiskt godtagbart gallsyrakomplexbildande adsorbatpreparat
SE445013B (sv) 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
JPH01172324A (ja) 1987-12-15 1989-07-07 Armour Internatl Co コレスチラミン組成物及びその製造法
US5178854A (en) 1988-03-24 1993-01-12 Taisho Pharmaceutical Co., Ltd. Cholesterol-lowering agents
EP0334673B1 (en) * 1988-03-24 1993-10-20 Taisho Pharmaceutical Co. Ltd Cholesterol-lowering agents
JPH02286621A (ja) 1989-04-26 1990-11-26 Mitsubishi Kasei Corp 経口コレステロール低下剤
DE4121127A1 (de) * 1991-06-26 1993-01-14 Rettenmaier & Soehne Gmbh & Co Hilfsstoff zur trockenen direkttablettierung und verfahren zur herstellung desselben
JP2712056B2 (ja) * 1992-01-14 1998-02-10 久光製薬株式会社 コレステロール低下剤
JP3552285B2 (ja) 1993-08-03 2004-08-11 三菱化学株式会社 経口コレステロール低下剤
TW438608B (en) 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin

Also Published As

Publication number Publication date
AU4572697A (en) 1998-05-11
JP4010585B2 (ja) 2007-11-21
DE69712033D1 (de) 2002-05-23
WO1998016237A1 (en) 1998-04-23
AU723340B2 (en) 2000-08-24
ATE216248T1 (de) 2002-05-15
UA51686C2 (uk) 2002-12-16
EP0873129B1 (en) 2002-04-17
CA2240402A1 (en) 1998-04-23
TW528605B (en) 2003-04-21
EP0873129A1 (en) 1998-10-28
ID21038A (id) 1999-04-08
CN1204965A (zh) 1999-01-13
KR19990072020A (ko) 1999-09-27
DE69712033T2 (de) 2002-08-22
PT873129E (pt) 2002-09-30
CN1111413C (zh) 2003-06-18
US6197290B1 (en) 2001-03-06
JPH10114661A (ja) 1998-05-06
DK0873129T3 (da) 2002-07-01
RU2180219C2 (ru) 2002-03-10

Similar Documents

Publication Publication Date Title
BG100933A (en) Polymer coated tablets comprising amoxycilin and clavulanate
IS4329A (is) Fjöleiningaskammtar í töfluformi sem innihalda prótónupumpublokkara
CA2274074A1 (en) Novel compounds with analgesic effect
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
WO1996017587A3 (en) Oral compositions containing stabilized stannous compounds
CA2395331A1 (en) Pharmaceutical compositions providing enhanced drug concentrations
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
DE69701532T2 (de) Orale zusammensetzung gegen zahnbelag
EP1435240A3 (en) Solid oral dosage form comprising a combination of methformin and glibenclamide
ES2176792T3 (es) Tabletas que contienen una resina de intercambio ionico.
PT90466A (pt) Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina
AU5683796A (en) Novel pharmaceutical pellet formulation
TR199701294T1 (xx) Amoksisilin ve klavulanik asitten olu�an terkip.
PL332724A1 (en) Local anaesthetic for extracorporeal use
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
RU95121837A (ru) Фармацевтическая композиция, обладающая иммуномоделирующим и гиполипидемическим действием
DE69722594D1 (de) Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül
NZ505080A (en) Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid
EP0761209A3 (en) Controlled release formulations of ranitidine
MX9804798A (es) Nuevos compuestos con efecto analgesico.
NO964775L (no) Fast farmasöytisk adenosinholdig preparat